| The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care C Casper British journal of haematology 129 (1), 3-17, 2005 | 528 | 2005 |
| International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, ... Blood, The Journal of the American Society of Hematology 129 (12), 1646-1657, 2017 | 492 | 2017 |
| Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial F Van Rhee, RS Wong, N Munshi, JF Rossi, XY Ke, A Fosså, D Simpson, ... The lancet oncology 15 (9), 966-974, 2014 | 453 | 2014 |
| Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology LR Baden, S Swaminathan, M Angarone, G Blouin, BC Camins, C Casper, ... Journal of the National Comprehensive Cancer Network 14 (7), 882-913, 2016 | 353 | 2016 |
| International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease F Van Rhee, P Voorhees, A Dispenzieri, A Fosså, G Srkalovic, M Ide, ... Blood, The Journal of the American Society of Hematology 132 (20), 2115-2124, 2018 | 313 | 2018 |
| A phase I, open-label study of siltuximab, an anti–IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease R Kurzrock, PM Voorhees, C Casper, RR Furman, L Fayad, S Lonial, ... Clinical cancer research 19 (13), 3659-3670, 2013 | 304 | 2013 |
| Prevention and treatment of cancer-related infections LR Baden, W Bensinger, M Angarone, C Casper, ER Dubberke, ... Journal of the National Comprehensive Cancer Network 10 (11), 1412-1445, 2012 | 291 | 2012 |
| Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment C Casper, WG Nichols, ML Huang, L Corey, A Wald Blood 103 (5), 1632-1634, 2004 | 279 | 2004 |
| Siltuximab, a novel anti–interleukin-6 monoclonal antibody, for Castleman's disease F Van Rhee, L Fayad, P Voorhees, R Furman, S Lonial, H Borghaei, ... Journal of clinical oncology 28 (23), 3701-3708, 2010 | 271 | 2010 |
| Treatment of cancer in sub-Saharan Africa TP Kingham, OI Alatise, V Vanderpuye, C Casper, FA Abantanga, ... The lancet oncology 14 (4), e158-e167, 2013 | 270 | 2013 |
| Epidemiology, pathophysiology, and treatment of Kaposi sarcoma—associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease RJ Sullivan, L Pantanowitz, C Casper, J Stebbing, BJ Dezube Clinical Infectious Diseases 47 (9), 1209-1215, 2008 | 210 | 2008 |
| Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma BM Grande, DS Gerhard, A Jiang, NB Griner, JS Abramson, TB Alexander, ... Blood, The Journal of the American Society of Hematology 133 (12), 1313-1324, 2019 | 205 | 2019 |
| Valganciclovir for suppression of human herpesvirus–8 replication: a randomized, double-blind, placebo-controlled, crossover trial C Casper, EM Krantz, L Corey, SR Kuntz, J Wang, S Selke, S Hamilton, ... The Journal of infectious diseases 198 (1), 23-30, 2008 | 172 | 2008 |
| Prevention and treatment of cancer-related infections Memorial Sloan-Kettering Cancer Center Journal of the National Comprehensive Cancer Network 6 (2), 122-122, 2008 | 150 | 2008 |
| Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection CJ Achenbach, RD Harrington, S Dhanireddy, HM Crane, C Casper, ... Clinical infectious diseases 54 (3), 424-433, 2012 | 149 | 2012 |
| Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response HQ Nguyen, AS Magaret, MM Kitahata, SE Van Rompaey, A Wald, ... Aids 22 (8), 937-945, 2008 | 144 | 2008 |
| The increasing burden of HIV-associated malignancies in resource-limited regions C Casper Annual review of medicine 62, 157-170, 2011 | 133 | 2011 |
| Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment S Gantt, C Casper Current opinion in infectious diseases 24 (4), 295-301, 2011 | 129 | 2011 |
| How I treat influenza in patients with hematologic malignancies C Casper, J Englund, M Boeckh Blood, The Journal of the American Society of Hematology 115 (7), 1331-1342, 2010 | 127 | 2010 |
| Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy CJ Achenbach, SR Cole, MM Kitahata, C Casper, JH Willig, MJ Mugavero, ... Aids 25 (5), 691-700, 2011 | 126 | 2011 |
